|
Editorial
Guest Editorial
Original Articles
-
Karen Dineen Wagner, Joan Rosenbaum Asarnow, Benedetto Vitiello, Gregory Clarke, Martin Keller, Graham J. Emslie, Neal Ryan, Giovanna Porta, Satish Iyengar, Louise Ritz, Jamie Zelanzny, Matthew Onorato, David Brent
-
Greg Clarke, John Dickerson, Christina M. Gullion, Lynn L. DeBar
-
Graham J. Emslie, Betsy D. Kennard, Taryn L. Mayes, Paul A. Nakonezny, Lian Zhu, Rongrong Tao, Carroll Hughes, Paul Croarkin
-
Wael Shamseddeen, Gregory Clarke, Martin B. Keller, Karen Dineen Wagner, Boris Birmaher, Graham J. Emslie, Neal Ryan, Joan Rosenbaum Asarnow, Giovanna Porta, David A. Brent
-
Erika E. Forbes, Stephanie D. Stepp, Ronald E. Dahl, Neal D. Ryan, Diana Whalen, David A. Axelson, Boris Birmaher, Jennifer S. Silk
-
Apurva Prakash, Evelyn Lobo, Christopher J. Kratochvil, Roy N. Tamura, Beth A. Pangallo, Kristin E. Bullok, Tonya Quinlan, Graham J. Emslie, John S. March
-
Paul E. Croarkin, Christopher A. Wall, Paul A. Nakonezny, Jeylan S. Buyukdura, Mustafa M. Husain, Shirlene M. Sampson, Graham J. Emslie, F. Andrew Kozel
-
W. Burleson Daviss, Rasim Diler
-
Sunita M. Stewart, Alex Simmons, Ehsan Habibpour
-
Kenneth B. Wells, Lingqi Tang, Gabrielle A. Carlson, Joan Rosenbaum Asarnow
|
Often free issues are sponsored by pharma. Who’s the sponsor of this one?
Oh, pharma is represented alright, with some of their favorite KOL’s
Co- author of PAXIL 329 (wagner), Martin Keller, Koplewicz (of the adhd ‘ransom notes ad campaign fame) and Gabrielle Carlson:
The AACAP 2009 January Psychopharmacology Update Institute faculty includes:
Gabrielle A. Carlson, M.D.
Advisor/Consultant: Bristol-Myers Squibb Company, Eli Lilly and Company, Otsuka America Pharmaceutical, Inc., Validus
Honorarium and Travel Expenses: American Academy of Child & Adolescent Psychiatry, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Shire Pharmaceuticals, Inc.
Research Funding: Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Otsuka America Pharmaceutical, Inc.
Spouse Advisor/Consultant: Eli Lilly and Company, H. Lundbeck A/S
——
It’s always tainted isn’t it. Maybe we should start a card collector’s game with KOL’s on the cards, who should be the number card to attain? Biederman? Nemeroff? so much competition!
I saw a psychiatric nurse describe a man as “resisting” and “uncooperative” because no matter how many times she repeated herself, he did not understand English. He was gentle as a baby deer. For some reason the nurse needed to see him as a threat.
“Problems with authority” works both ways. I blanch to think about these “free” articles being used by mental health professionals in State and County institutions to justify the drugging of children and teenagers to make them suffer quietly and to internalize blame for their failure to be happy and compliant with authority figures who don’t have time to treat them as anything other than “problems” like “treatment resistant depression”.
I don’t know whether you have already seen this article from Plos Medicine, but thought it might be of interest:
A Comparison of DSM-IV and DSM-5 Panel Members’ Financial Associations with Industry: A Pernicious Problem Persists
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001190
If there’s anything you’ve shown us, it’s that different studies of the same subject can have varying results, and that there can be a fair amount of chicanery in how they are analyzed, presented, and supported.
A fast look at any of these articles shows a good reason not to pay any attention–the number of citations that make a global claim based on a single study. This is a basic of hack work, but belongs nowhere in a respectable medical journal.
This thing was bought and paid for.